Key Bridge Compliance »

Citius Pharmaceuticals shares owned by Key Bridge Compliance

Quarter-by-quarter ownership of Citius Pharmaceuticals (CTXR) shares owned by Key Bridge Compliance from 13F filings

Historical chart of Key Bridge Compliance investment in Citius Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Citius Pharmaceuticals held by Key Bridge Compliance consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Pharmaceuticals by Key Bridge Compliance

Quarter filed Position value Share count Share price at filing
2023-09-30 $106k 154k 0.68

More positions owned by Key Bridge Compliance

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Apple (AAPL)
Ishares Tr Intl Sel Div Etf (IDV)
Eli Lilly & Co. (LLY)
TJX Companies (TJX)
Occidental Petroleum Corporation (OXY)
Chevron Corporation (CVX)
UnitedHealth (UNH)
Home Depot (HD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Cme (CME)

View all positions for Key Bridge Compliance

Top funds holding Citius Pharmaceuticals

Vanguard Group
Advisor Group Holdings
Charles Schwab Investment Management
Bank of New York Mellon
HighTower Advisors
Bank of America Corporation
Barclays
Inspire Advisors
Rhumbline Advisers
Wealth Advisory Solutions
UBS Group
Arkadios Wealth Advisors
Jane Street
William Blair $ Company
Goldman Sachs Group

View all funds holding Citius Pharmaceuticals